Corvus Pharmaceuticals
CRVS
CRVS
56 hedge funds and large institutions have $44.9M invested in Corvus Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $66.7M → $44.9M (-$21.8M)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
48% less call options, than puts
Call options by funds: $174K | Put options by funds: $337K
Holders
56
Holding in Top 10
1
Calls
$174K
Puts
$337K
Top Buyers
| 1 | +$2.14M | |
| 2 | +$551K | |
| 3 | +$155K | |
| 4 |
JSC
Jackson Square Capital
San Francisco,
California
|
+$105K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$95.9K |
Top Sellers
| 1 | -$1.27M | |
| 2 | -$699K | |
| 3 | -$603K | |
| 4 |
Two Sigma Advisers
New York
|
-$568K |
| 5 |
Millennium Management
New York
|
-$322K |